131I therapy:: Inpatient or outpatient?

被引:0
作者
de Klerk, JMH [1 ]
机构
[1] Univ Utrecht, Med Ctr, Dept Nucl Med, NL-3508 GA Utrecht, Netherlands
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页码:1876 / 1878
页数:3
相关论文
共 17 条
[1]   Radiation dose rates from patients receiving iodine-131 therapy for carcinoma of the thyroid [J].
Barrington, SF ;
Kettle, AG ;
ODoherty, MJ ;
Wells, CP ;
Somer, EJR ;
Coakley, AJ .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1996, 23 (02) :123-130
[2]   Radiation exposure of the families of outpatients treated with radioiodine (iodine-131) for hyperthyroidism [J].
Barrington, SF ;
O'Doherty, MJ ;
Kettle, AG ;
Thomson, WH ;
Mountford, PJ ;
Burrell, DN ;
Farrell, RJ ;
Batchelor, S ;
Seed, P ;
Harding, LK .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (07) :686-692
[3]   Regulations and policies on radioiodine I-131 therapy in Europe [J].
Beckers, C .
THYROID, 1997, 7 (02) :221-224
[4]  
Coover LR, 2000, J NUCL MED, V41, P1868
[5]  
*COUNC EUR UN, 1996, J EUR COMM L, V159
[6]  
deKlerk JMH, 1997, J NUCL MED, V38, P372
[7]  
European Commission, 1998, RAD PROT 97 RAD PROT
[8]  
Harbert John C., 1996, P975
[9]  
Harbert John C., 1996, P951
[10]   Drug therapy - Treatment of benign nodular thyroid disease [J].
Hermus, AR ;
Huysmans, DA .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (20) :1438-1447